Medicamen Biotech Ltd is a globally recognized pharmaceutical company engaged in the manufacturing and marketing of a wide range of pharmaceutical formulations, including tablets, capsules, syrups, and ointments. With its inception in 1993, the company operates two state-of-the-art manufacturing facilities in Bhiwadi, Rajasthan, and Haridwar, Uttarakhand. These facilities are equipped to produce both beta-lactam and non-beta-lactam products, catering to domestic and international markets.
The company expanded its product range to include analgesics, anti-bacterial, anti-filarial, and anti-TB drugs, aligning with government projects and fulfilling international demand. In 2015, Shivalik Rasayan Limited became the new promoter through a takeover, enhancing its strategic capabilities. Furthermore, in 2019, Medicamen Biotech acquired OPAL Pharmaceuticals, expanding its global footprint. Recently, in January 2022, the company launched 12 oncology products in the domestic market, reflecting its commitment to addressing diverse medical needs and maintaining competitive pricing.
